Singular Health Group Ltd (ASX: SHG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Singular Health Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Singular Health Group Ltd (ASX: SHG)
Latest News
Ask a Fund Manager
2 small-cap ASX shares the market hasn't woken up to yet
Healthcare Shares
3 ASX health care shares that burned the market today
Share Gainers
These 3 ASX healthcare shares are soaring today. Why?
Share Market News
Why the Singular Health (ASX:SHG) share price opened nearly 10% higher today
Share Fallers
Why Fortescue, Freedom Foods, QBE, & Singular Health are sinking
Share Fallers
Why the Singular Health (ASX:SHG) share price is sinking 13% today
Share Market News
Why is the Singular Health (ASX:SHG) share price frozen?
Share Market News
The Singular Health (ASX:SHG) share price launched 27% higher today
Share Gainers
Why the Singular Health (ASX:SHG) share price is shooting 10% higher
Share Gainers
The Singular Health (ASX:SHG) share price is now up 140% since its IPO
Share Gainers
Singular Health (ASX:SHG) share price rockets 100% higher following IPO
Share Gainers
Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher
SHG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Singular Health Group Ltd
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
SHG Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
20 Dec 2024 | $0.24 | $0.02 | 9.09% | 1,731,886 | $0.23 | $0.24 | $0.22 |
19 Dec 2024 | $0.22 | $0.00 | 0.00% | 1,229,090 | $0.22 | $0.23 | $0.19 |
18 Dec 2024 | $0.22 | $0.02 | 10.00% | 6,232,751 | $0.21 | $0.24 | $0.19 |
17 Dec 2024 | $0.20 | $0.03 | 17.14% | 5,939,746 | $0.18 | $0.22 | $0.18 |
16 Dec 2024 | $0.18 | $0.00 | 0.00% | 1,377,993 | $0.19 | $0.19 | $0.17 |
13 Dec 2024 | $0.18 | $-0.01 | -5.56% | 1,519,462 | $0.18 | $0.19 | $0.17 |
12 Dec 2024 | $0.18 | $0.03 | 19.35% | 2,648,031 | $0.17 | $0.18 | $0.16 |
11 Dec 2024 | $0.16 | $0.02 | 14.81% | 2,265,454 | $0.13 | $0.17 | $0.13 |
10 Dec 2024 | $0.14 | $0.02 | 16.67% | 899,314 | $0.12 | $0.14 | $0.12 |
09 Dec 2024 | $0.12 | $-0.03 | -20.69% | 1,967,502 | $0.15 | $0.15 | $0.12 |
06 Dec 2024 | $0.15 | $0.00 | 0.00% | 1,789,822 | $0.15 | $0.15 | $0.13 |
05 Dec 2024 | $0.14 | $0.03 | 26.09% | 2,633,952 | $0.12 | $0.15 | $0.12 |
04 Dec 2024 | $0.12 | $0.00 | 0.00% | 1,356,558 | $0.12 | $0.13 | $0.12 |
03 Dec 2024 | $0.12 | $0.00 | 0.00% | 873,543 | $0.12 | $0.12 | $0.12 |
02 Dec 2024 | $0.12 | $0.01 | 9.09% | 1,697,050 | $0.12 | $0.12 | $0.11 |
29 Nov 2024 | $0.11 | $-0.01 | -8.33% | 2,652,011 | $0.12 | $0.12 | $0.10 |
28 Nov 2024 | $0.12 | $0.00 | 0.00% | 1,736,895 | $0.12 | $0.12 | $0.12 |
27 Nov 2024 | $0.12 | $0.00 | 0.00% | 1,083,444 | $0.12 | $0.12 | $0.12 |
26 Nov 2024 | $0.12 | $0.00 | 0.00% | 393,825 | $0.12 | $0.12 | $0.12 |
25 Nov 2024 | $0.12 | $0.01 | 9.09% | 1,279,472 | $0.12 | $0.12 | $0.11 |
22 Nov 2024 | $0.11 | $-0.01 | -8.70% | 811,061 | $0.12 | $0.12 | $0.11 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
25 Jul 2024 | Denning Chong | Exercise | 1,500,000 | $136,500 |
Conversion of securities. 7,200,000 Rights
|
25 Jul 2024 | Andrew Just | Issued | 336,364 | $33,300 |
Director remuneration. Estimated value
|
25 Jul 2024 | Denning Chong | Issued | 10,000,000 | $910,000 |
Issue of securities. 17,200,000 Rights
|
25 Jul 2024 | Denning Chong | Issued | 1,500,000 | $136,500 |
Conversion of securities.
|
25 Jul 2024 | Howard Digby | Issued | 378,218 | $37,443 |
Director remuneration. Estimated value
|
27 Feb 2024 | Denning Chong | Cancelled | 1,200,000 | $156,000 |
Cancellation of securities. 87,00,000 Rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Andrew Ian Just | Non-Executive Director | Jan 2021 |
Mr Just was formerly the Regional Director Asia Pacific for Radiometer, a Danaher Company and is currently CEO of Aeris Environmental. He has 30 years' global experience in delivering growth and scale competencies with Fortune 500 companies, including GE Healthcare, Danaher, Stryker, and Cochlear. Andrew has senior roles across business functions, with expertise in sales and marketing, performance management, commercial transactions, and operations in both turnaround and growth environments. He is also a Member of the Risk Committee.
|
Mr Howard Andrew Digby | Non-Executive ChairmanNon-Executive Director | Jan 2021 |
Mr Digby began his career at IBM and has spent over 25 years managing technology-related businesses in the Asia Pacific region, of which 11 years were spent in Hong Kong. Prior to returning to Perth, Howard was with The Economist Group as Regional Managing Director. He has also held senior regional management roles at Adobe and Gartner.
|
Mr Denning Sang-Tatt Chong | Chief Executive OfficerManaging Director | Apr 2023 |
Mr Chong has been the principal of James Chong Lawyers since 2004. Denning has had the opportunity to assist across a spectrum of the community - from ASX listed companies and cross border type transactions, to local communities. Denning holds positions with various prominent property development companies, including currently being a director of the Australian subsidiaries of a prominent SGX listed property developer, with a property portfolio. He is also a director of a boutique venture capital business focusing on property, financial and medical technology sectors. He is a Member of the Risk Committee
|
Mr Steven Douglas Wood | Company Secretary |
-
|
|
Steven Douglas Wood | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Marin And Sons Strategies Llc | 13,636,363 | 6.60% |
Mr Sim Tek Tan | 9,003,091 | 4.35% |
Chong Ling Diamond Cheong | 7,065,754 | 3.42% |
Mr Craig Sellars | 6,666,667 | 3.22% |
Statewide National Services Pty Ltd | 6,000,000 | 2.90% |
Skyline Corporation Pty Ltd | 5,068,539 | 2.45% |
Jli Enterprises Pty Ltd <Jli A/C> | 4,900,000 | 2.37% |
Jcc Health Pty Ltd <The Jde Medvr A/C> | 4,640,869 | 2.24% |
Sylvan Capital Pte Ltd | 3,500,000 | 1.69% |
Ms Wei Zheng | 3,326,224 | 1.61% |
Mr Anthony Galvin Khang Chuang Lim | 3,192,359 | 1.54% |
Jde Capital Pty Ltd <Jde Capital A/C> | 3,167,706 | 1.53% |
Mr Qingyuan Zhang | 3,136,364 | 1.52% |
Mr Pak Lim Kong | 3,132,292 | 1.51% |
Garry Tet Kheng Chong | 3,000,000 | 1.45% |
Mr Kostadin Jivkov Manolev | 2,828,821 | 1.37% |
Mr Ilia Manolev | 2,713,878 | 1.31% |
Peninsula Treescape Pty Ltd <The Cardinals A/C> | 2,700,000 | 1.31% |
Raffe Capital Pty Ltd | 2,272,727 | 1.10% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 2,154,683 | 1.06% |